R Fuchs Selected Research

Potassium

2/2001

Inhibition of clathrin-dependent endocytosis has multiple effects on human rhinovirus serotype 2 cell entry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Fuchs Research Topics

Disease

2	Infections 10/2001 - 02/2001
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2017
1	Muscular Diseases (Myopathy) 12/2015
1	Lymphoma (Lymphomas) 01/2009
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2009
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 08/2005
1	Colorectal Neoplasms (Colorectal Cancer) 08/2005
1	Balkan Nephropathy (Balkan Endemic Nephropathy) 01/2005
1	Kidney Diseases (Kidney Disease) 01/2005
1	Body Weight (Weight, Body) 05/2003
1	Virus Diseases (Viral Diseases) 02/2001
1	Pain (Aches) 01/2000

Drug/Important Bio-Agent (IBA)

1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2017
1	Imatinib Mesylate (Gleevec)FDA Link 11/2017
1	InterferonsIBA 11/2017
1	MicroRNAs (MicroRNA)IBA 12/2015
1	Proteins (Proteins, Gene)FDA Link 12/2015
1	Rituximab (Mabthera)FDA Link 01/2009
1	Leucovorin (Folinic Acid)FDA Link 08/2005
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2005
1	Fluorouracil (Carac)FDA LinkGeneric 08/2005
1	ochratoxin AIBA 01/2005
1	MycotoxinsIBA 01/2005
1	LipidsIBA 05/2003
1	Cycloheximide (Cicloheximide)IBA 05/2003
1	Lipoproteins (Lipoprotein)IBA 05/2003
1	Dynamins (Dynamin)IBA 10/2001
1	PotassiumIBA 02/2001
1	ClathrinIBA 02/2001

Therapy/Procedure

1	Time-to-Treatment 01/2009
1	Drug Therapy (Chemotherapy) 01/2009
1	Therapeutics 01/2009
1	Analgesia 01/2000
1	Neuroleptanalgesia 01/2000